SOBR Safe, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated December 22, 2025, details a private placement transaction entered into by SOBR Safe, Inc. (SOBR). The transaction was announced on December 24, 2025, and closed on December 29, 2025. The Company is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol "SOBR."
Key Financial Metrics and Transaction Details
The filing reports the following specific financial data related to the capital raise:
- Gross Proceeds: $2,000,002.20
- Use of Proceeds: Working capital and general corporate purposes.
- Securities Issued:
- 370,000 shares of Common Stock at $1.55 per share.
- 920,324 Pre-Funded Warrants at $1.5499 per warrant (exercisable at $0.0001).
- 1,290,324 Series C Warrants (5-year term, $1.30 exercise price).
- 1,290,324 Series D Warrants (24-month term, $1.30 exercise price).
- Transaction Costs:
- Placement Agent Fee: 7.5% of gross cash proceeds to H.C. Wainwright & Co., LLC (HCW).
- Legal Expenses: Up to $25,000 for HCW counsel.
- Non-accountable Expenses: $10,000.
- Tail Fee: $33,333 paid to Aegis Capital Corp.
The filing does not provide current revenue, profit, cash flow, margins, debt, or liquidity metrics outside of the proceeds from this specific transaction.
Material Changes and Agreements
The Company entered into several material definitive agreements:
- Securities Purchase Agreement: Established the terms of the private placement with institutional investors.
- Placement Agent Agreement: Engaged HCW as the exclusive placement agent. HCW received warrants to purchase 96,774 shares at $1.9375 per share (Placement Agent Warrants) and is entitled to future fees upon warrant exercises.
- Registration Rights Agreement: The Company agreed to file a resale registration statement within 20 calendar days, with effectiveness required within 60 days (or 90 days if reviewed by the SEC).
- Lock-Up Provisions: The Company is restricted from issuing equity for 45 days and entering into Variable Rate Transactions for one year following the Effective Date.
Outlook, Risks, and Contingencies
Management intends to utilize the net proceeds for working capital and general corporate purposes. The filing highlights the following risks and contingencies:
- Dilution: The issuance of common stock and warrants will increase the total share count. Beneficial ownership limitations cap exercise at 4.99% (or 9.99% at election) of outstanding shares.
- Warrant Terms: Series C and Series D warrants include cash settlement rights based on Black-Scholes value in the event of a fundamental transaction.
- Regulatory Compliance: Securities were sold unregistered under Section 4(a)(2) and Rule 506(b) of Regulation D to accredited investors only.
Key Facts for Investor Verification
- Verify the exact net proceeds after deducting the 7.5% placement fee, legal costs, and tail fees.
- Confirm the total number of shares outstanding post-closing to assess immediate dilution from the 370,000 shares and 920,324 pre-funded warrants.
- Monitor the filing of the resale registration statement, which is due within 20 days of the agreement execution.
- Review the full text of the warrant agreements (Exhibits 10.2, 10.3, 10.4) for specific anti-dilution provisions and exercise limitations.
- Check for any subsequent filings regarding the use of proceeds or changes in the Company's liquidity position.